Forbes @Forbes
A federal judge ruled Friday morning that Martin Shkreli, a former hedge fund manager convicted of securities fraud in 2017, must pay $64.6 million in fines to states that filed an antitrust lawsuit over his dramatic increase to the price of Daraprim, a life-saving drug, in 2015. https://t.co/ybaPczX5Lg — PolitiTweet.org